regulusrx.com (RGLS): Rasio rega marang bathi tumrap wutah
Will Regulus Therapeutics (RGLS) become a leader in the kidney therapy niche through its unique RNA developments? This PEG ratio chart confirms the potential for expansion in the polycystic kidney disease segment, where the value is fixed at 0.00. The issuer's financial stability relies on future insurance payments and licensing fees from partners involved in creating innovative genetic medicines.
Regulus Therapeutics (RGLS) - rincian metrik lan laporan keuangan
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Regulus Therapeutics|RGLS - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal regulusrx.com|RGLS - Gunggung utang perusahaan|Rasio utang marang aset resik Regulus Therapeutics Inc|RGLS - Utang jangka dawa perusahaan|Utang jangka cendhak Regulus Therapeutics|Rasio jangkoan perantara regulusrx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
RGLS - Bathi resik|Proyeksi bathi mangsa ngarep Regulus Therapeutics|RGLS - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Regulus|RGLS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Regulus Therapeutics Inc|RGLS - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Regulus Therapeutics|RGLS - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan regulusrx.com|RGLS - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Regulus Therapeutics
Analisis umum perusahaan:Regulus Therapeutics, Inc., RGLS
The PEG ratio compares the P/E multiple with earnings growth rates to determine whether an asset's current valuation is fair relative to its growth trajectory. By analyzing the undervaluation-to-growth indicator on the GURU.Markets platform, an investor can identify the potential of Regulus Therapeutics (RGLS) by assessing how closely the market price aligns with the company's ambitions to develop breakthrough microRNA therapies for the treatment of polycystic kidney disease.
Perusahaan pesaing
Pangali PEG Tempus AI, Inc (TEM)|Rasio rega marang bathi tumrap wutah Qiagen Group QGEN|Isis Pharmaceuticals - Rasio rega marang bathi tumrap wutah|RGEN: Pangali rega marang bathi tumrap wutah|RNA - Pangali PEG|CRISPR Therapeutics (CRSP) - Rasio rega marang bathi tumrap wutah|WGS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah RARE|BEAM: Koefisien bali modal nimbang wutah|Pangali rega marang bathi tumrap wutah SRPT (Sarepta Therapeutics, Inc.)|Rasio nilai perusahaan marang wutah bathi TWST|Pangali PEG TXG (10x Genomics)|Koefisien bali modal nimbang wutah NTLA|Stoke - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah BioLife|Wave Life Sciences (WVE) - Rasio rega marang bathi tumrap wutah|mazetx.com - Koefisien bali modal nimbang wutah|SION (Sionna Therapeutics) - Pangali PEG|Pangali PEG Prime Medicine Inc|Rasio rega marang bathi tumrap wutah Taysha (TSHA)|QURE: Rasio kapitalisasi marang bathi lan wutah|Pangali PEG MGTX (MeiraGTx Holdings plc)|regenxbio.com (RGNX) - Rega marang bathi kanthi panyesuaian wutah|SLDB: Pangali rega marang bathi tumrap wutah|OCGN - Pangali PEG|PACB (Pacific Biosciences of California) - Pangali rega marang bathi tumrap wutah|BNTC: Rasio nilai perusahaan marang wutah bathi|DSGN (Design Therapeutics) - Pangali PEG|rocketpharma.com (RCKT) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali PEG FDMT|Pangali rega marang bathi tumrap wutah lexeotx.com LXEO|Rasio rega marang bathi tumrap wutah Korro Bio KRRO|Kapitalisasi marang bathi resik kanthi nimbang wutah Editas Corp (EDIT)|SLN - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah PRQR (ProQR Therapeutics N.V.)|CDXS: Pangali PEG|Rasio rega marang wutah bathi resik Sangamo Therapeutics Inc. SGMO|Rasio rega marang bathi tumrap wutah Nautilus Biotechnology, Inc.|Rasio rega marang bathi tumrap wutah MGX|Rasio rega marang bathi tumrap wutah Precision BioSciences (DTIL)|Kapitalisasi marang bathi resik kanthi nimbang wutah generationbio.com|Pangali PEG BOLD (Boundless Bio)|XCUR: Rasio P/E diaturake wutah|IMNN - Rasio rega marang bathi tumrap wutah|PHIO (Phio Pharmaceuticals) - Rasio P/E diaturake wutah|MBIO: Pangali PEG|TransCode Therapeutics, Inc. (RNAZ) - Pangali PEG|Rasio rega marang bathi tumrap wutah Bionano Genomics Inc.|APDN: Koefisien bali modal nimbang wutah|Pangali PEG BLUE|IPA - Rega marang bathi kanthi panyesuaian wutah|Pangali PEG OMGA (Omega Therapeutics)|Rasio rega marang wutah bathi resik singulargenomics.com|SYRS: Pangali rega marang bathi tumrap wutah|TBIO - Pangali PEG|TRACON (TCON) - Rasio rega marang bathi tumrap wutah|UBX (Unity Biotechnology, Inc) - Rasio rega marang bathi tumrap wutah
